However, inflammatory biomarkers CRP and IL-6 were significantly reduced in the colchicine group, compared with the placebo (both P < 0.001).29 In our study, adding colchicine 0.5 mg twice to standard care for 12 weeks did not significantly decrease the HDRS of patients with HF. Here, IL6 is linked to hydrops fetalis.